Idiopathic pulmonary fibrosis : The Lancet
Links shared publicly online about this topic.
- 185total visits
Idiopathic pulmonary fibrosis : The Lancet
View full resource at thelancet.com
Tags: Pulmonary Fibrosis, Doctor, Pulmonology
Most Recently Shared on June 28, 2011 at 3:56 pm By:
Read a Seminar on idiopathic pulmonary fibrosis http://t.co/po3jdl7
CasesBlog - Medical and Health Blog: Pathogenesis of idiopathic pulmonary fibrosis - 2011 Lancet review
casesblog.blogspot.com — “Health News Updated Daily by Assistant Professor at University of Chicago, Internist and Allergist” View full resource at casesblog.blogspot.com
Most Recently Shared on March 7, 2012 at 1:47 pm By:
Richard L.Trader,Sr Therapist, Health Executive, and Physician Assistant
Pathogenesis of idiopathic pulmonary fibrosis - 2011 Lancet review: Idiopathic pulmonary fibrosis (IPF) is a dev... http://t.co/9b8bf5ja
New Insights Come From Tracing Cells That Scar Lungs
medicalnewstoday.com — “Tracking individual cells within the lung as they move around and multiply has given Duke University researchers new insights into the causes of Idiopathic Pulmonary Fibrosis (IPF) a disease whic” View full resource at medicalnewstoday.com
Most Recently Shared on December 5, 2011 at 8:05 am By:
New Insights Come From Tracing Cells That Scar Lungs http://t.co/rT1vfQEW #biology
Neutrophil chemotaxis in granulomatosis with polyangiitis (Wegener’s) and idiopathic pulmonary fibrosis
erj.ersjournals.com — “Neutrophil chemotaxis in granulomatosis with polyangiitis (Wegener’s) and idiopathic pulmonary fibrosis” View full resource at erj.ersjournals.com
Most Recently Shared on November 17, 2011 at 6:48 pm By:
Neutrophil chemotaxis in granulomatosis with polyangiitis (Wegener’s) and idiopathic pulmonary fibrosis. http://t.co/1og5CqVQ
Idiopathic Pulmonary Fibrosis Drug Market to Grow to $4.6 Billion in 2020 - MarketWatch
marketwatch.com — “Idiopathic Pulmonary Fibrosis Drug Market to Grow to $4.6 Billion in 2020 - MarketWatch” View full resource at marketwatch.com
Most Recently Shared on November 11, 2011 at 7:36 pm By:
John Carroll Health Communicator
RT @RyanMFierce: pulmonary fibrosis market poised hit $4.6B in 2020 with $NVS, Intermune et al launching IPF drugs PR: http://t.co/AljrZ4pM
ACP: InternistWeekly - 1 November 2011
acpinternist.org — “ACP: InternistWeekly - 1 November 2011” View full resource at acpinternist.org
Most Recently Shared on October 31, 2011 at 5:39 pm By:
Minorities bring med school applications to all-time high http://t.co/JehgEAl4 #meded
Lung disorder drug regimen found harmful (10/27/11)
mc.vanderbilt.edu — “The standard treatment for idiopathic pulmonary fibrosis (IPF) that has been widely used for the last 20 years is not only ineffective, but appears to be dangerous, according to the findings of a clinical trial.” View full resource at mc.vanderbilt.edu
Most Recently Shared on October 28, 2011 at 4:18 am By:
Otis B Rickman, D.O. Internist, Pulmonologist, Physician, and Doctor
PANTHER trial halts triple therapy arm of IPF study (prednisone, azathioprine, NAC) due to potential harm http://t.co/DhFeA2xf
Clinical Alert: Commonly Used Three-drug Regimen for Idiopathic Pulmonary Fibrosis Found Harmful
nlm.nih.gov — “Clinical Alert: Commonly Used Three-drug Regimen for Idiopathic Pulmonary Fibrosis Found Harmful” View full resource at nlm.nih.gov
Most Recently Shared on October 24, 2011 at 2:39 pm By:
RT @nnlmscr: Clinical Alert: Commonly Used Three-drug Regimen for Idiopathic Pulmonary Fibrosis Found Harmful http://t.co/gcn93cG8
Respiratory Research | Abstract | Activated MCTC Mast Cells Infiltrate Diseased Lung Areas in Cystic Fibrosis and Idiopathic Pulmonary Fibrosis
respiratory-research.com — “Although mast cells are regarded as important regulators of inflammation and tissue remodelling, their role in cystic fibrosis (CF) and idiopathic pulmonary fibrosis (IPF) has remained less studied. This study investigates the densities and phenotypes of mast cell populations in multiple lung compartments from patients with CF, IPF and never smoking controls.” View full resource at respiratory-research.com
Most Recently Shared on October 20, 2011 at 10:00 pm By:
Juan C. Ivancevich, MD Physician, Doctor, Internist, and Allergist
Activated MCTC Mast Cells Infiltrate Diseased Lung Areas in Cystic Fibrosis and Idiopathic Pulmonary Fibrosis http://t.co/Q6zpqswa
Patients With Lung-Scarring Disease And Cough Have Worse Prognosis
medicalnewstoday.com — “A new analysis has found that coughing may signal trouble for patients with the lung-scarring disease known as idiopathic pulmonary fibrosis. The study, published in the journal Respirology, found” View full resource at medicalnewstoday.com
Most Recently Shared on October 20, 2011 at 8:05 am By:
Patients With Lung-Scarring Disease And Cough Have Worse Prognosis http://t.co/OY2vX2cV #asthma
Progression of lung fibrosis blocked in mouse model
labspaces.net — “A study by researchers at the University of California, San Diego School of Medicine may lead to a way to prevent the progression, or induce the regression, of lung injury that results from use of the anti-cancer chemotherapy drug Bleomycin. Pulmonary fibrosis caused by this drug, as well as Idiopathic Pulmonary Fibrosis (IPF) from unknown causes, affect nearly five million people worldwide. No th” View full resource at labspaces.net
Most Recently Shared on October 6, 2011 at 3:00 pm By:
Progression of lung fibrosis blocked in mouse model - http://t.co/WwRPiwlh
Drug Shows Promise Against Deadly Lung Disease - Drugs.com MedNews
drugs.com — “An experimental drug may offer a thin ray of hope to people suffering from the rapidly fatal lung disease known as idiopathic pulmonary fibrosis. The compound,” View full resource at drugs.com
Most Recently Shared on September 21, 2011 at 10:59 pm By:
Drug Shows Promise Against Deadly Lung Disease - http://t.co/1X8ykSU9
Drug Shows Promise Against Deadly Lung Disease - Yahoo! News
news.yahoo.com — “Read 'Drug Shows Promise Against Deadly Lung Disease' on Yahoo! News. WEDNESDAY, Sept. 21 (HealthDay News) -- An experimental drug may offer a thin ray of hope to people suffering from the rapidly fatal lung disease known as idiopathic pulmonary fibrosis.” View full resource at news.yahoo.com
Most Recently Shared on September 21, 2011 at 10:42 pm By:
Drug Shows Promise Against Deadly Lung Disease: WEDNESDAY, Sept. 21 (HealthDay News) -- An experimental drug ma... http://t.co/sgqqFF0C
Drug Shows Promise Against Deadly Lung Disease - Drugs.com MedNews
drugs.com — “An experimental drug may offer a thin ray of hope to people suffering from the rapidly fatal lung disease known as idiopathic pulmonary fibrosis. The compound,” View full resource at drugs.com
Most Recently Shared on September 21, 2011 at 10:12 pm By:
Drugs and Devices OW OW Health
Drug Shows Promise Against Deadly Lung Disease: WEDNESDAY, Sept. 21 -- An experimental drug may offer a th... http://t.co/hKBUgZAq #drug
Drug Shows Promise Against Deadly Lung Disease - MSN Health - Health Topics
health.msn.com — “In early trial highest dose slowed progression of idiopathic pulmonary fibrosis” View full resource at health.msn.com
Most Recently Shared on September 21, 2011 at 9:50 pm By:
Drug Shows Promise Against Deadly Lung Disease: http://t.co/IoqwykS6
Press Release Archive
us.boehringer-ingelheim.com — “Press Release Archive” View full resource at us.boehringer-ingelheim.com
Most Recently Shared on September 21, 2011 at 9:05 pm By:
Phase II data on BI’s investigational compound for idiopathic pulmonary fibrosis (#IPF) published today in #NEJM http://ht.ly/6B3te
Advertisement
